Dr. Vokes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 Holcombe Blvd
Houston, TX 77030Phone+1 877-632-6789
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2016 - 2019- Brigham and Women's HospitalResidency, Internal Medicine, 2013 - 2016
Harvard Medical SchoolClass of 2013
Certifications & Licensure
FL State Medical License 2021 - Present
GA State Medical License 2022 - 2026
TX State Medical License 2020 - 2026
AL State Medical License 2022 - 2025
AZ State Medical License 2022 - 2025
LA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastati...Mehmet Altan, Ruoxing Li, Ziyi Li, Runzhe Chen, Ajay Sheshadri
Journal for Immunotherapy of Cancer. 2024-12-25 - Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma.Giuseppe Tarantino, Cora A Ricker, Annette Wang, William Ge, Tyler J Aprati
Science Advances. 2024-11-29 - 5 citationsCTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun
Nature. 2024-11-01
Journal Articles
- Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid TumorsJeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature
Lectures
- Distinct immunogenomic properties of melanomas with stable disease as best response to immune checkpoint blockade (ICB).2019 ASCO Annual Meeting - 6/1/2019
- Genomic correlates of response to immune checkpoint blockade in microsatellite stable solid tumors.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell CarcinomaFebruary 5th, 2021- Integrated Molecular Drivers Coordinate Biological and Clinical States in MelanomaNovember 23rd, 2020
Damon Runyon Announces Recipients of Physician-Scientist Training AwardMay 15th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
